acrobat clinical research limited
acrobat clinical research limited Company Information
Company Number
10084392
Next Accounts
Mar 2025
Directors
Shareholders
carol bradshaw
jeremy stephen bradshaw
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
30 st pauls square, birmingham, west midlands, B3 1QZ
Website
-acrobat clinical research limited Estimated Valuation
Pomanda estimates the enterprise value of ACROBAT CLINICAL RESEARCH LIMITED at £69.3k based on a Turnover of £140k and 0.49x industry multiple (adjusted for size and gross margin).
acrobat clinical research limited Estimated Valuation
Pomanda estimates the enterprise value of ACROBAT CLINICAL RESEARCH LIMITED at £12.7k based on an EBITDA of £3.8k and a 3.3x industry multiple (adjusted for size and gross margin).
acrobat clinical research limited Estimated Valuation
Pomanda estimates the enterprise value of ACROBAT CLINICAL RESEARCH LIMITED at £95.5k based on Net Assets of £40.7k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Acrobat Clinical Research Limited Overview
Acrobat Clinical Research Limited is a dissolved company that was located in west midlands, B3 1QZ with a Companies House number of 10084392. It operated in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in March 2016, it's largest shareholder was carol bradshaw with a 91.7% stake. The last turnover for Acrobat Clinical Research Limited was estimated at £140k.
Upgrade for unlimited company reports & a free credit check
Acrobat Clinical Research Limited Health Check
Pomanda's financial health check has awarded Acrobat Clinical Research Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £140k, make it smaller than the average company (£1.1m)
- Acrobat Clinical Research Limited
£1.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (5.3%)
- Acrobat Clinical Research Limited
5.3% - Industry AVG
Production
with a gross margin of 26.2%, this company has a higher cost of product (45.7%)
- Acrobat Clinical Research Limited
45.7% - Industry AVG
Profitability
an operating margin of 2.7% make it less profitable than the average company (6.5%)
- Acrobat Clinical Research Limited
6.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (15)
1 - Acrobat Clinical Research Limited
15 - Industry AVG
Pay Structure
on an average salary of £42.2k, the company has an equivalent pay structure (£42.2k)
- Acrobat Clinical Research Limited
£42.2k - Industry AVG
Efficiency
resulting in sales per employee of £140k, this is more efficient (£109.5k)
- Acrobat Clinical Research Limited
£109.5k - Industry AVG
Debtor Days
it gets paid by customers after 157 days, this is later than average (53 days)
- Acrobat Clinical Research Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 67 days, this is slower than average (33 days)
- Acrobat Clinical Research Limited
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Acrobat Clinical Research Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Acrobat Clinical Research Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 33.1%, this is a lower level of debt than the average (52.5%)
33.1% - Acrobat Clinical Research Limited
52.5% - Industry AVG
ACROBAT CLINICAL RESEARCH LIMITED financials
Acrobat Clinical Research Limited's latest turnover from March 2020 is estimated at £140 thousand and the company has net assets of £40.7 thousand. According to their latest financial statements, Acrobat Clinical Research Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | 1 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|
| Tangible Assets | 260 | 178 | 238 | 317 |
| Intangible Assets | ||||
| Investments & Other | ||||
| Debtors (Due After 1 year) | ||||
| Total Fixed Assets | 260 | 178 | 238 | 317 |
| Stock & work in progress | ||||
| Trade Debtors | 60,543 | 60,595 | 41,566 | 45,066 |
| Group Debtors | ||||
| Misc Debtors | ||||
| Cash | ||||
| misc current assets | ||||
| total current assets | 60,543 | 60,595 | 41,566 | 45,066 |
| total assets | 60,803 | 60,773 | 41,804 | 45,383 |
| Bank overdraft | ||||
| Bank loan | ||||
| Trade Creditors | 19,196 | 23,218 | 20,671 | 20,464 |
| Group/Directors Accounts | 944 | |||
| other short term finances | ||||
| hp & lease commitments | ||||
| other current liabilities | ||||
| total current liabilities | 20,140 | 23,218 | 20,671 | 20,464 |
| loans | ||||
| hp & lease commitments | ||||
| Accruals and Deferred Income | ||||
| other liabilities | 22,046 | |||
| provisions | ||||
| total long term liabilities | 22,046 | |||
| total liabilities | 20,140 | 23,218 | 20,671 | 42,510 |
| net assets | 40,663 | 37,555 | 21,133 | 2,873 |
| total shareholders funds | 40,663 | 37,555 | 21,133 | 2,873 |
| Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | 104 | |||
| Amortisation | ||||
| Tax | ||||
| Stock | ||||
| Debtors | -52 | 19,029 | -3,500 | 45,066 |
| Creditors | -4,022 | 2,547 | 207 | 20,464 |
| Accruals and Deferred Income | ||||
| Deferred Taxes & Provisions | ||||
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | ||||
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | ||||
| Group/Directors Accounts | 944 | |||
| Other Short Term Loans | ||||
| Long term loans | ||||
| Hire Purchase and Lease Commitments | ||||
| other long term liabilities | -22,046 | 22,046 | ||
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | ||||
| overdraft | ||||
| change in cash |
acrobat clinical research limited Credit Report and Business Information
Acrobat Clinical Research Limited Competitor Analysis
Perform a competitor analysis for acrobat clinical research limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in B 3 area or any other competitors across 12 key performance metrics.
acrobat clinical research limited Ownership
ACROBAT CLINICAL RESEARCH LIMITED group structure
Acrobat Clinical Research Limited has no subsidiary companies.
Ultimate parent company
ACROBAT CLINICAL RESEARCH LIMITED
10084392
acrobat clinical research limited directors
Acrobat Clinical Research Limited currently has 1 director, Dr Carol Bradshaw serving since Mar 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Carol Bradshaw | United Kingdom | 64 years | Mar 2016 | - | Director |
P&L
March 2020turnover
140k
-20%
operating profit
3.8k
0%
gross margin
26.3%
+0.79%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2020net assets
40.7k
+0.08%
total assets
60.8k
0%
cash
0
0%
net assets
Total assets minus all liabilities
acrobat clinical research limited company details
company number
10084392
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
March 2016
age
9
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2020
previous names
N/A
accountant
TAXASSIST ACCOUNTANTS
auditor
-
address
30 st pauls square, birmingham, west midlands, B3 1QZ
Bank
-
Legal Advisor
-
acrobat clinical research limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to acrobat clinical research limited.
acrobat clinical research limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ACROBAT CLINICAL RESEARCH LIMITED. This can take several minutes, an email will notify you when this has completed.
acrobat clinical research limited Companies House Filings - See Documents
| date | description | view/download |
|---|
